Cytotoxicity of a newly synthesized nitroxide derivative of 4-ferrocenecarboxyl-2,2,6,6-tetramethylpiperidine-1-oxyl in high metastatic lung tumor cells

Pharmazie

Volumn 61, Issue 12, 2006, Pages 1028-1033

  Wu, Y ^a   Tang, W ^a   Li, C L ^a   Liu, J W ^a   Miao, L D ^a   Han, J ^a   Lan, M B ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 FERROCENECARBOXYL 2,2,6,6 TETRAMETHYLPIPERIDINE 1 OXYL; CASPASE 3; CASPASE 8; CASPASE INHIBITOR; CATALASE; NITROXIDE DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG CARCINOMA; LUNG TUMOR; METASTASIS; TUMOR CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASE 8; CATALASE; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FERROUS COMPOUNDS; G1 PHASE; HUMANS; INDICATORS AND REAGENTS; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; NEOPLASM METASTASIS; PIPERIDINES; SUPEROXIDE DISMUTASE;

EID: 33845929615     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48: 589-601.
2. Baker JE, Froncisz W, Joseph J, Kalyanaraman B (1997) Spin label oximetry to assess extracellular oxygen during myocardial ischemia. Free Radic Biol Med 22: 109-115.
3. Brasch RC, London DA, Wesbey GE, Tozer TN, Nitecki DE, Williams RD, Doemeny J, Tuck LD, Lallemand DP (1983) Work in progress: Nuclear magnetic resonance study of a paramagnetic nitroxide contrast agent for enhancement of renal structures in experimental animals. Radiology 147: 773-779.
4. Cardoso SM, Pereira C, Oliveira CR (1998) Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 26: 3-13.
5. Cheung WMW, Hui WS, Chu PWK, Chiu SW, Ip NY (2000) Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochromocytoma PC12 cells. FEBS Lett 486: 291-296.
6. Ewing JF, Janero DR (1995) Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal Biochem 232: 243-248.
7. Gariboldi MB, Lucchi S, Caserini C, Supino R, Oliva C, Monti C (1998) Antiproliferative effect of the piperidine nitroxide tempol on neoplastic and nonneoplastic mammalian cellines. Free Radic Biol Med 24:913-923.
8. Gariboldi MB, Rimoldi V, Supino R, Favini E, Monti E (2000) The nitroxide tempol induces oxidative stress, p21WAF1/CIP1 and cell death in HL60 cells. Free Radic Bio Med 29: 633-641.
9. Gariboldi MB, Ravizza R, Petterino C, Castagnaro M, Finocchiaro G, Monti E (2003) Study of in vitro and in vivo effects of the piperidine nitroxide Tempol - A potential new therapeutic agent for gliomas. Eur J Cancer 39: 829-837.
10. Heerdt BG, Houston MA, Anthony GM, Augenlicht LH (1998) Mitochondrial membrane potential (DCmt) in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Res 58: 2869-2875.
11. Howard BJ, Yatin S, Hensley K, Allen KL, Kelly JP, Carney J, Butterfield DA (1996) Prevention of hyperoxia-induced alterations in synaptosomal membrance-associated proteins by N-tert-butyl-alpha-phenylnitrone and 4-hydroxy-2,2,6,6,-tetramethylpiperidin-1-oxyl (TEMPOL). J Neurochem 67: 2045-2050.
12. Koceva-Chyla A, Kochman A, Glebska J, Gwoździnski K, Jóźwiak Z, Met́odiewa D (2000) Tempicol-3, a novel piperidine-N-oxide stable radical and antioxidant, with low toxicity acts as apoptosis inducer and cell proliferation modifier of Yoshida Sarcoma cells in vivo. Anticancer Res 20:4611-4618.
13. Lai CS, Hopwood LE, Swartz HM (1980) ESR studies on membrane fluidity of Chinese hamster ovary cells grown on microcairiers and in suspension. Exp Cell Res 130: 437-442.
14. Lan MB, Wu Y, Han J, Yuan HH (2005) Application and synthesis of a novel nitroxide derivative, 4-ferrocenecarboxyl-2,2,6,6-tetramethyl piperidine-1-oxyl (FC-TEMPO). China patent: CN 1709874
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
16. Li J, Huang C-Y, Zheng R-L, Cui K-R, Li J-F (2000) Hydrogen peroxide induces apoptosis in human hepatoma cells and alters cell redox status. Cell Bio Int 24: 9-23.
17. Mader K, Stosser R, Borchert H-H (1992) Transcutaneous absorption of nitroxide radicals detected in vivo by means of x-band ESR. Pharmazie 47: 946-947
18. Metodiewa D, Kochman A, Skolimowski J, Gebicka L, Koska C (1999) Metexyl (4-methoxy-2,2,6,6-tetramethylpiperidine-1-oxyl) as an oxygen radicals scavenger and apoptosis inducer in vivo. Anticancer Res 19: 5259-5264.
19. Metodiewa D, Kochman A, Gebicha L, Skolimowski A (2000) Evidence for peroxidative oxidation of substituted piperidine nitroxides, acting as apoptosis inducers in yoshida sarcoma cells in vivo. Anticancer Res 20: 2421-2426.
20. Mitchell JB, Samuni A, Finkelstein E, Ahn MS, Gamson J, Russo A (1991) Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic. Tempol Arch Biochem Biophys 289: 62-70.
21. Monti E, Cova D, Guido E, Morelli R, Oliva C (1996) Protective effect of the nitroxide TEMPOL against the cardiotoxicity of adnamycin. Free Radic Biol Med 21: 463-470.
22. Osella D, Ferrali M, Zanello P, Laschi F, Fonatni M, Nerri C, Cavigiolio G (2000) On the mechanism of the antitumor activity of ferrocenium derivatives. Inorg Chim Acta 306: 42-48.
23. Popova LV, Babin VN, Belousov YA, Nekrasov YS, Snegireva AE, Borodina NP, Shaposhnikova GM, Bychenko OB, Raevskii PM, Morozova NB, Iiyina AL, Shitkov KG (1993) Antitumor effects of binuclear ferrocene derivatives. Appl Organomet Chem 7: 85-94.
24. Sosnovsky G, Rao NUM (1991) In the search for new anticancer drugs. XXIII: exploration of a predictive design for anticancer drugs of carbohydrates containing N-ntirosochloroethylamino, N-nitrosomethyl, and N-nitrosoaminoxyl components. J Pharm Sci 80: 693-699.
25. Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U (2005) Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice. Cancer 103: 1302-1313.
26. Tamura H, Miwa M (1997) DNA cleaving activity and cytotoxic activity of ferricenium cations. Chem Lett 11: 1177-1178.
27. Tomonori K, Munehiro N, Shinzi K, Masateru M (1977) The preparation of ferrocenethiocarboxylic acid derivatives and their spectral properties. J Organometal Chem 129: 189-196.
28. Top S, Vessières A, Leclercq G, Quivy J, Tang J, Vaissermann J, Huche M, Jaouen G (2003) Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines. Chem Eur J 9: 5223-5236.
29. Vashisht Gopal YN, Jayaraju D, Kondapi AK (2000) Topoisomerase II poisoning and antineoplastic action by DNA-Nonbinding diacetyl and dicarboxaldoxime derivatives of ferrocene. Arch Biochem Biophys 376: 229-235.
30. Voest EE, Van Faassen E, Van Asbeck BS, Neijt JP, Marx JJM (1986) Increased hydrogen peroxide concentration in human tumor cells due to a nitroxide free radical. Biochim. Biophys Acta 1136: 113-118.